POSC
What one share of Positron holds
Electromedical and Electrotherapeutic Apparatus
Nature of Business. Positron is a medical technology company that co-develops, manufactures and sells PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions.
Positron’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$0.31 |
| Cash and investments | $0.01 |
| Debt | $0.00 |
| Book value | −$0.02 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $0.02 | −$0.09 | — | −$0.07 | — | −$0.02 |
| 2025 | $0.01 | −$0.34 | — | −$0.15 | — | $0.04 |